Star Tribune: “U of M is expanding research of experimental treatment that saved COVID-19 patients”

“University of Minnesota researchers announced this week that they are exploring an aerosolized version of the liquid treatment that could be administered more easily and to more patients. […]

The researchers still need to convince the Food and Drug Administration that it is an effective treatment for acute respiratory distress syndrome (ARDS), a severe lung disorder caused by COVID-19 and other infectious diseases. But they are confident enough that they have created a startup company, Herald Therapeutics, and the university has obtained patents in the United States, Canada, China, India, and Mexico and is seeking one from the European Union.”

Read full article (Star Tribune)